Results 51 to 60 of about 11,039 (220)
Achondroplasia is a genetic disorder where there is underdevelopment and shortening of the long bones formed by endochondral ossification without abnormalities of cartilage formation.
Youssef Motiaa +3 more
doaj +1 more source
Effect of the G375C and G346E achondroplasia mutations on FGFR3 activation. [PDF]
Two mutations in FGFR3, G380R and G375C are known to cause achondroplasia, the most common form of human dwarfism. The G380R mutation accounts for 98% of the achondroplasia cases, and thus has been studied extensively.
Lijuan He +4 more
doaj +1 more source
Anesthesia Management in Achondroplasia: A Case Report
Achondroplasia is the result of a mutation in the gene encoding the type 3 receptor for a fibroblast growth factor. This abnormality results in malformation endochondral ossification.
Houman Teymourian +5 more
doaj +1 more source
Children with achondroplasia, the most common cause of short stature, pose several challenges for the anesthesiologists who care for them. Although a rare condition, individuals affected with achondroplasia have a normal life span and frequently present to the operating room for much needed otolaryngologic, neurosurgical, and orthopedic procedures. The
Trevor Whitwell, Antonio Gonzalez Fiol
+5 more sources
Living With Hypochondroplasia: A Qualitative Exploration of Children's and Caregivers' Experiences, Challenges, and Unmet Needs. [PDF]
Summary of findings from a qualitative study on the experiences and unmet needs of children with hypochondroplasia and their caregivers. ABSTRACT Background Hypochondroplasia (HCH) is a rare genetic skeletal dysplasia characterized by short stature, disproportionate limbs, and complications such as learning differences.
Oehrlein EM +8 more
europepmc +2 more sources
Achondroplasia is the most common short stature skeletal dysplasia (1:20,000–30,000), but the risk of adverse health outcomes from cardiovascular diseases, pain, poor function, excess weight, and sleep apnea is unclear.
J. Hoover-Fong +14 more
semanticscholar +1 more source
Background Achondroplasia is associated with disproportionate short stature and significant and potentially severe medical complications. Vosoritide is the first medicine to treat the underlying cause of achondroplasia and data from phase 3 and phase 2 ...
R. Savarirayan +13 more
semanticscholar +1 more source
ABSTRACT To evaluate the prevalence of psychiatric signs and symptoms and describe psychotherapeutic and psychopharmacological interventions among children with osteogenesis imperfecta (OI). PRISMA guidelines were followed, and the study was registered in PROSPERO (CRD42024588284). Studies (n = 1419) were identified across five databases.
Julia M. Morales +13 more
wiley +1 more source
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia. [PDF]
Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been ...
Celine Saint-Laurent +10 more
doaj +1 more source
Birth prevalence of achondroplasia: A systematic literature review and meta‐analysis
Achondroplasia is a genetic disorder that results in disproportionate short stature. The true prevalence of achondroplasia is unknown as estimates vary widely. This systematic literature review and meta‐analysis was conducted to better estimate worldwide
Pamela K Foreman +5 more
semanticscholar +1 more source

